June 26, 2025 - 21:13

GundersenAIR has made a significant advancement by incorporating Hinckley Medical’s OneDose system into its operations. This strategic move marks GundersenAIR as the first flight emergency medical service (EMS) to adopt this innovative technology, which is designed to streamline workflows and enhance the efficiency of medical operations in the air.
The OneDose system offers a range of benefits, including improved medication management and reduced risk of errors during critical situations. By integrating this technology, GundersenAIR aims to bolster its commitment to providing high-quality patient care while ensuring that its medical teams are equipped with the best tools available.
This adoption not only signifies a leap forward in emergency medical services but also sets a precedent for other flight EMS organizations. As the healthcare landscape continues to evolve, GundersenAIR's proactive approach highlights the importance of embracing technological advancements to improve patient outcomes and operational effectiveness in the field.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...